Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda

Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy, if shown to be safe, could facilitate greater access to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hepatol Commun
Hlavní autoři: Grant, Philip, Shumbusho, Fabienne, Van Nuil, Jennifer Ilo, Kateera, Fredrick, Mukherjee, Joia, Kabahizi, Jules, Ntaganda, Fabien, Nsanzimana, Sabin, Mbituyumuremyi, Aimable, Damascene, Makuza Jean, Muvunyi, Claude Mambo, Mukabatsinda, Constance, Musabeyezu, Emmanuel, Ntirenganya, Cyprien, Gupta, Neil
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7109339/
https://ncbi.nlm.nih.gov/pubmed/32258951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1482
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky